Back to search results

Physical Activity for Older Women with Gynecologic Cancers

This study, called Fit4Treatment, is looking at how to best help older women with gynecologic cancers (like ovarian, endometrial, uterine, or cervical cancer) become more physically active. You can join if you are over 60, have one of these cancers, and are receiving or planning to receive treatments like chemotherapy or immunotherapy. The study is testing a core program that uses a Fitbit activity tracker and app, along with four additional components: a symptom-tailored app, an exercise partner, engagement with your oncology doctor, and coaching. The main goal is to see which of these combinations leads to the biggest increase in physical activity over 24 weeks. The study aims to enroll 192 participants, but its current status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 192 women.
What's involved
The intervention will be delivered over 12 weeks, followed by a 12-week follow-up period.
Compensation
Not stated in the trial record.
Follow-up
Physical activity will be measured at 24 weeks after the start of the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05743517

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Recruiting
NAAges 60+InterventionalSupportive care
Northwestern University
~192 participants
Updated 2026-05-29 on ClinicalTrials.gov
What's tested:Fit4Treatment

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Physical Activity
Measured over 24 weeks

Conditions

Ovary Cancer
Endometrial Cancer
Uterine Cancer
Cervical Cancer
Cervix Cancer
Vulvar Cancer
Vaginal Cancer

Explore related trials

Cervical CarcinomaEndometrial CarcinomaMalignant Ovarian NeoplasmVaginal CarcinomaVulvar Carcinoma

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Emma Barber, MD, MS · PRINCIPAL_INVESTIGATOR · Northwestern University

Who to contact

Anne Grace, PhD
[email protected]
312-503-4165
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Female; \> 60 years of age
Diagnosis of endometrial/uterine, ovarian, cervical or vulvar/vaginal cancer
Undergoing or planning to undergo any systemic treatment for a gynecologic malignancy (e.g., chemotherapy, immunotherapy, anti-angiogenic therapies, targeted therapies, etc.)
Willing to try to identify an exercise partner to participate with them, if needed
Fluent in English

Exclusion

Uncontrolled cardiovascular disease or other major contraindications to physical activity
Active brain metastases
Cognitive or functional limitations that preclude a patient's ability to participate in the physical activity intervention
Pregnant women or prisoners

What this trial measures

  • Change in Physical Activity24 weeks

    The primary outcome of average steps per day over a 7 day period will be measured with Actigraph. Patients will wear an accelerometer for 7 days prior to study intervention, 7 days at the conclusion of the 12-week Fit4Treatment intervention, and 7 days at the conclusion of the 12 week follow up period.